全文获取类型
收费全文 | 338篇 |
免费 | 15篇 |
专业分类
林业 | 26篇 |
农学 | 11篇 |
69篇 | |
综合类 | 14篇 |
农作物 | 16篇 |
水产渔业 | 38篇 |
畜牧兽医 | 139篇 |
园艺 | 5篇 |
植物保护 | 35篇 |
出版年
2023年 | 2篇 |
2022年 | 4篇 |
2021年 | 8篇 |
2020年 | 6篇 |
2019年 | 8篇 |
2018年 | 6篇 |
2017年 | 8篇 |
2016年 | 17篇 |
2015年 | 18篇 |
2014年 | 13篇 |
2013年 | 20篇 |
2012年 | 25篇 |
2011年 | 28篇 |
2010年 | 13篇 |
2009年 | 10篇 |
2008年 | 22篇 |
2007年 | 21篇 |
2006年 | 27篇 |
2005年 | 21篇 |
2004年 | 21篇 |
2003年 | 25篇 |
2002年 | 15篇 |
2001年 | 5篇 |
2000年 | 6篇 |
1999年 | 1篇 |
1998年 | 2篇 |
1974年 | 1篇 |
排序方式: 共有353条查询结果,搜索用时 109 毫秒
351.
Shigeru Yamauchi Takayuki Yamagishi Kazuko Kirikoshi Mitsuyoshi Yatagai 《Journal of Wood Science》2017,63(2):183-191
Cesium adsorption by commercial charcoals was examined to elucidate the mechanisms for capturing cesium ions in aqueous solution. Changes in the adsorption ability of charcoals due to water extraction (water washing) were investigated to develop practical cesium adsorptives based on charcoal. The commercial charcoals examined included mangrove charcoal (MC) and ubamegashi (Quercus phillyraeoides A. Gray) bincho charcoal (BC). Data from the two charcoals were compared with those of Japanese oak (Quercus serrata Thunb. and/or Quercus crispula Blume) charcoal (OC) reported previously. Aqueous cesium chloride solution (2.50 × 10?5 mol/L) was used as a sample solution for the adsorption study. Charcoal powder was used as an adsorbent after passing through a 60-mesh sieve. The powders were characterized using methods, such as Raman spectroscopy, X-ray fluorescence spectrometry, and infrared photoacoustic spectroscopy. The results indicated that MC, which was manufactured at the lowest possible temperature and had the smallest specific surface area, possessed the greatest ability to adsorb cesium. The MC also had the great cesium-adsorption ability in weak acidic solution and maintained the ability even after lengthy extraction treatments. 相似文献
352.
The purpose of this study was to measure the dynamics of serum α1-acid glycoprotein (AGP) concentration in dogs with various
tumors, and to investigate the localization of AGP in some tissues using immunohistochemical staining. Sera were obtained
from 171 dogs bearing tumors of various types. Serum AGP concentration was measured by single radial immunodiffusion. Tumors
occurring in the liver and spleen were also investigated immunohistochemically using anti-canine AGP antibody. Mean serum
AGP levels were 749 ± 602 mg/L in dogs with carcinoma (n = 39), 1,014 ± 971 mg/L with sarcoma (n = 18), and 887 ± 935 mg/L with round cell tumors (n = 46), all significantly higher than serum AGP level in healthy dogs (n = 137, 364 ± 106 mg/L). Mean serum AGP levels were significantly higher than in healthy dogs in complex mammary gland carcinoma
(n = 5, 876 ± 721 mg/L), malignant melanoma (n = 7, 1,010 ± 821 mg/L), and hepatocellular carcinoma (n = 5, 936 ± 741 mg/L) among carcinomas, hemangiosarcoma (n = 5, 1,740 ± 1,323 mg/L) among sarcomas, and lymphoma (n = 19, 1,072 ± 965 mg/L) and histiocytic tumor (n = 6, 1,800 ± 1,387 mg/L) among round cell tumors. In an immunohistochemical investigation of AGP localization, both weak
and strong staining for anti-AGP antibody were seen in hepatic tissue in dogs with primary non-tumorous lesions originating
in the spleen (hematoma) and elevated serum AGP, but all tumor tissue in the spleen was negative. Among dogs with primary
tumor lesions of the spleen (hemangiosarcoma) and elevated serum AGP levels, both weak, moderate and strong staining for anti-AGP
antibody were seen in hepatic tissue, while strong positive staining was apparent in all tumorous tissue from the spleen.
In primary tumor lesions in the liver (hepatocellular carcinoma), both moderate and strong staining for anti-AGP antibody
were seen in normal hepatic tissue, and both weak, moderate and strong staining were seen in tumor tissues of the liver. AGP
levels thus appear to be elevated in dogs with carcinomas, sarcomas, and round cell tumors. With some of these malignant tumors,
localization of AGP in tumor tissue was seen. 相似文献
353.
Prognosis of canine patients with nasal tumors according to modified clinical stages based on computed tomography: a retrospective study 总被引:1,自引:0,他引:1
Kondo Y Matsunaga S Mochizuki M Kadosawa T Nakagawa T Nishimura R Sasaki N 《The Journal of veterinary medical science / the Japanese Society of Veterinary Science》2008,70(3):207-212
To evaluate the efficacy of clinical staging based on computed tomography (CT) imaging over the World Health Organization (WHO) staging system based on radiography for nasal tumors in dogs, a retrospective study was conducted. This study used 112 dogs that had nasal tumors; they had undergone radiography and CT and had been histologically confirmed as having nasal tumors. Among 112 dogs, 85 (75.9%) were diagnosed as adenocarcinoma. Then they were analyzed for survival time according to each staging system. More than 70% of the patients with adenocarcinoma were classified as having WHO stage III. The patients classified under WHO stage II tended to survive longer than those classified under WHO stage III. Dogs classified under WHO stage III were further grouped into CT stages III and IV, and CT stage III patients had a significantly longer survival time than CT stage IV patients. In addition, patients treated with a combination of surgery and radiation had a significantly longer survival time than the patients who did not receive any treatment in CT stage III. On the other hand, different treatment modalities did not show a significant difference in the survival time of CT stage IV dogs. The results suggest that WHO stage III dogs may have various levels of tumor progression, indicating that the CT staging system may be more accurate than the WHO staging system. 相似文献